ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

ALIM Alimera Sciences Inc

3,46
-0,22 (-5,98%)
02 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Alimera Sciences Inc ALIM NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,22 -5,98% 3,46 01:50:16
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
3,71 3,45 3,76 3,46 3,68
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202414:00GLOBEAlimera Sciences to Report First Quarter 2024 Financial..
20.3.202413:00GLOBEAlimera Sciences Reports Inducement Grants Under Nasdaq..
19.3.202413:00GLOBEAlimera Announces First Patient Randomized in Radiation..
08.3.202423:23EDGAR2Form S-8 - Securities to be offered to employees in employee..
07.3.202414:32EDGAR2Form 8-K - Current report
07.3.202413:30GLOBEAlimera Sciences Reports Fourth Quarter and Full Year 2023..
29.2.202414:00GLOBEAlimera Sciences to Report Fourth Quarter and Full Year 2023..
13.2.202422:43EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202422:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13.2.202421:27EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09.2.202423:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
09.2.202423:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
09.2.202423:08EDGAR2Form 8-K - Current report
08.2.202414:00GLOBEThe UK National Institute for Health and Care Excellence..
11.1.202418:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.1.202422:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
04.1.202422:01EDGAR2Form 8-K - Current report
04.1.202414:00GLOBEAlimera Completes Recruitment for the Synchronicity Study
02.1.202414:00GLOBEAlimera Sciences Names Elliot Maltz as Chief Financial..
13.12.202323:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.12.202323:09EDGAR2Form 8-K - Current report
12.12.202313:30GLOBEAlimera Sciences Appoints Todd Wood as President of U.S...
28.11.202322:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28.11.202322:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09.11.202300:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.11.202323:18EDGAR2Form 8-K - Current report
08.11.202322:30GLOBEAlimera Appoints Maggie A. Pax to Its Board of Directors
31.10.202313:00GLOBEAlimera Announces Scientific Data Highlighting ILUVIEN® To..
26.10.202313:39EDGAR2Form 8-K - Current report
26.10.202313:00GLOBEAlimera Sciences Reports Third Quarter 2023 Results
16.10.202314:00GLOBEAlimera Sciences to Report Third Quarter 2023 Financial..
11.10.202314:00GLOBEAlimera Announces Multiple Presentations Highlighting..
04.10.202323:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04.10.202322:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03.10.202314:00GLOBEAlimera Sciences Appoints Jason Werner as Chief Operating..
03.10.202313:00EDGAR2Form 8-K - Current report
15.9.202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.9.202314:00GLOBEAlimera Sciences to Present at the H.C. Wainwright 25th..
23.8.202312:01EDGAR2Form SC 13G - Statement of acquisition of beneficial..
18.8.202301:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.8.202323:17EDGAR2Form SC 13D/A - General statement of acquisition of..
15.8.202322:55EDGAR2Form 8-K - Current report
11.8.202323:09EDGAR2Form S-8 - Securities to be offered to employees in employee..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock